Arabic Arabic English English French French German German
dark

Puma Biotechnology Releases Updated Corporate Presentation

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, provided an update to the corporate presentation that its Chief Executive Officer and President, Alan H. Auerbach, presented at the virtual H.C. Wainwright BioConnect Conference, which began at 7:00 a.m. EST on Monday, January 10, 2022. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Travere Therapeutics Provides Corporate Update and 2022 Outlook

Next Post

TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy

Related Posts
Total
0
Share